What the research found

As we age, hematopoietic stem cells—the bone marrow cells that generate all blood and immune cells—appear to develop a form of persistent immune memory called trained immunity. Unlike adaptive immunity (which responds to specific threats), trained immunity is a hardwired, non-specific state of elevated alert that causes immune cells to respond more aggressively to stimuli. The research suggests this misdirected vigilance becomes self-perpetuating and contributes to chronic inflammation across the body.

The study identified SIRT3, a mitochondrial enzyme, as a molecular "off switch" for this maladaptive process. SIRT3 levels naturally decline with age, and when depleted, stem cells lose their ability to restrain this inflammatory training. Restoring SIRT3 function—at least in the experimental system studied—appeared to reverse some of the age-related changes in how these cells behave.

Why it matters for you

If validated, this work could explain why inflammatory biomarkers like CRP, IL-6, and TNF-α tend to rise steadily with age even in apparently healthy people. Rather than infection or lifestyle alone, you might be observing a cellular-level immune dysregulation originating in bone marrow. This is relevant if you've noticed stable or worsening inflammatory markers despite good sleep, training discipline, or supplement use—the source may be stem cell programming, not just state-level factors you can directly control.

SIRT3 is a NAD+-dependent enzyme, which connects to why some users experiment with NAD+ precursors (NMN, NR) or sirtuins activators. This research suggests a mechanistic reason those interventions might matter for inflammaging—though the leap from mouse models to measurable changes in your biomarkers remains unproven. It also hints that mitochondrial health in immune cells, not just muscle or brain, may be an underappreciated driver of systemic aging signals.

Caveats

  • Preliminary mechanistic work; human efficacy unknown
  • SIRT3 restoration was likely tested in controlled experimental conditions, not real-world supplementation or lifestyle
  • Trained immunity in aging is plausible but not yet a consensus model
  • No information on whether SIRT3 changes are reversible in humans or how large an effect size to expect
  • Unclear whether interventions can meaningfully restore SIRT3 or whether other redundant pathways compensate with age